Patent details
EP2400977 Title: PEPTIDOMIMETIC CYCLIC COMPOUNDS FOR TREATING RETINITIS PIGMENTOSA
Basic Information
- Publication number:
- EP2400977
- PCT Application Number:
- PCT/US/2010/025575
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107068751
- PCT Publication Number:
- WO/2010/099436
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PEPTIDOMIMETIC CYCLIC COMPOUNDS FOR TREATING RETINITIS PIGMENTOSA
- French Title of Invention:
- COMPOSÉS CYCLIQUES PEPTIDOMIMÉTIQUES POUR LE TRAITEMENT DE LA RÉTINITE PIGMENTAIRE
- German Title of Invention:
- PEPTIDOMIMETISCHE ZYKLISCHE VERBINDUNGEN ZUR BEHANDLUNG VON RETINITIS PIGMENTOSA
- SPC Number:
Dates
- Filing date:
- 26/02/2010
- Grant date:
- 23/07/2014
- EP Publication Date:
- 23/07/2014
- PCT Publication Date:
- 02/09/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/01/2012
- EP B1 Publication Date:
- 23/07/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/02/2015
- Expiration date:
- 26/02/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/02/2010
- Name:
- Mimetogen Pharmaceuticals Inc.
- Address:
- 1000 De La Gauchetiere Street West Suite 900, Montreal, Quebec H3B 5H4, Canada (CA)
Inventor
1
- Name:
- CUMBERLIDGE Garth
- Address:
- United States (US)
2
- Name:
- SARAGOVI H., Uri
- Address:
- Canada (CA)
3
- Name:
- MEEROVITCH Karen
- Address:
- Canada (CA)
Priority
- Priority Number:
- 208806 P
- Priority Date:
- 27/02/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/12;
| Filing date | Document type | Number of pages |
|---|